Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 7Tumor-Agnostic 2Sarcoma 1Lymphoid 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Breast Neoplasms 54Triple Negative Breast Neoplasms 8Carcinoma, Intraductal, Noninfiltrating 6Breast Neoplasms, Male 4Melanoma 3Inflammatory Breast Neoplasms 3Breast Carcinoma In Situ 3Brain Neoplasms 3Sarcoma 2Prostatic Neoplasms 2Lung Neoplasms 2Carcinoma, Merkel Cell 2Carcinoma, Ductal, Breast 2Bone Neoplasms 2To Evaluate the Safety of Taurine in Preventing Acute Radiation Skin Injury Induced by Adjuvant Radiotherapy in Breast Cancer Patients 1Squamous Cell Carcinoma of Head and Neck 1Pain 1Osteosarcoma 1Neoplasms 1Neoplasm Metastasis 1Mycosis Fungoides 1Meningeal Carcinomatosis 1Lymphoma, Non-Hodgkin 1Lymphoma 1Glioblastoma 1Fatigue 1Estrogen Receptor Positive 1Deception 1Cardiotoxicity 1Carcinoma, Squamous Cell 1

Interventions

pembrolizumab 3talimogene laherparepvec 1spartalizumab 1nanocis 1fludarabine 1avelumab 1atezolizumab 1aldesleukin 1Technetium-99 1TTI-621 1Radiation 1Proton Pump Inhibitors 1Nivolumab 1Lasers 1Ipilimumab 1Interleukin-2 1Infracyanine green 1Indocyanine Green 1Hydrocortisone 1Cyclophosphamide 1Bleomycin 1Antineoplastic Protocols 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Squamous Cell × Radiation × Breast × Clear all
NCT02890368 2023-04-05

Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoides

Pfizer

Phase 1 Terminated
56 enrolled
BreastDermatologicLymphoidSarcoma

Breast Neoplasms, Carcinoma, Squamous Cell, Melanoma, Mycosis Fungoides, Sarcoma, Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡